Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
J
Jagsonpal Pharmaceuticals Ltd
Score 68/100• Decent
Jagsonpal Pharmaceuticals Ltd shows potential but faces significant challenges in profitability and valuation metrics. Caution is advised for investors.
Company’s Health94/100
Valuation 20/100 · PB 6.1967
Technical Avoid
1M 0.429% 6M -5.556% 1Y 2.653%
Confidence100%
Low leverage (D/E)No promoter pledge
#91
View details ➜
J
J B Chemicals and Pharmaceuticals Ltd
Score 68/100• Decent
J B Chemicals and Pharmaceuticals Ltd shows decent potential with a stable growth outlook, but investors should be cautious of execution risks and valuation metrics.
Company’s Health95/100
Valuation 20/100 · PB 7.6731
Technical Avoid
1M 0.341% 6M 6.691% 1Y -14.214%
Confidence100%
Low leverage (D/E)No promoter pledge
#92
View details ➜
I
IPCA Laboratories Ltd
Score 68/100• Decent
IPCA Laboratories Ltd shows potential for growth, but investors should be cautious due to profitability inconsistencies and valuation concerns.
Company’s Health80/100
Valuation 40/100 · PB 3.8448
Technical Avoid
1M -3.67% 6M -7.764% 1Y -19.99%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#93
View details ➜
I
Indoco Remedies Ltd
Score 68/100• Decent
Indoco Remedies Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
Company’s Health56/100
Valuation 60/100 · PB 2.5263
Technical Avoid
1M -3.425% 6M 21.549% 1Y -10.068%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#94
View details ➜
H
Hindustan Bio Sciences Ltd
Score 68/100• Decent
Hindustan Bio Sciences Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised for investors.
Company’s Health33/100
Valuation 20/100 · PB 8.4512
Technical Avoid
1M -13.976% 6M -9.842% 1Y -32.972%
Confidence100%
No promoter pledgeHealthy profit margins
Weak ROEHigh debt/equity
#95
View details ➜
G
Gufic Biosciences Ltd
Score 68/100• Decent
Gufic Biosciences Ltd shows potential for growth in a promising sector, but faces challenges in profitability and valuation metrics. Investors should proceed with caution.
Company’s Health90/100
Valuation 20/100 · PB 5.429
Technical Avoid
1M -8.696% 6M -9.874% 1Y -25.784%
Confidence100%
No promoter pledge
#96
View details ➜
F
Fortis Healthcare Ltd
Score 68/100• Decent
Fortis Healthcare Ltd shows potential in a growing sector but faces challenges in execution and competition. Caution is advised.
Company’s Health67/100
Valuation 20/100 · PB 8.4232
Technical Watch
1M 7.58% 6M 50.759% 1Y 63.767%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#97
View details ➜
D
Dr Lalchandani Labs Ltd
Score 68/100• Decent
Dr Lalchandani Labs Ltd shows potential in a growing sector, but faces challenges in growth consistency and valuation metrics. Caution is advised.
Company’s Health46/100
Valuation 100/100 · PB 0.989
Technical Avoid
1M 9.268% 6M 84.219% 1Y 15.758%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#98
View details ➜
D
Dr Agarwal's Eye Hospital Ltd
Score 68/100• Decent
Dr Agarwal's Eye Hospital Ltd shows potential for growth, but faces challenges in profitability and valuation metrics compared to peers.
Company’s Health68/100
Valuation 20/100 · PB 12.0716
Technical Avoid
1M 7.331% 6M 22.15% 1Y 2.682%
Confidence100%
Healthy profit marginsDecent revenue growth
High debt/equityPromoter pledge present
#99
View details ➜
D
DocMode Health Technologies Ltd
Score 68/100• Risky
DocMode Health Technologies Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health44/100
Valuation 40/100 · PB 4.6201
Technical Momentum
1M 52.728% 6M 124.817% 1Y 50.061%
Confidence100%
Weak ROEPromoter pledge present
#100
View details ➜
C
Concord Biotech Ltd
Score 68/100• Decent
Concord Biotech Ltd shows potential for growth but faces challenges in valuation and execution risks.
Company’s Health94/100
Valuation 20/100 · PB 8.3325
Technical Avoid
1M -11.858% 6M -3.14% 1Y -21.117%
Confidence100%
Low leverage (D/E)No promoter pledge
#101
View details ➜
B
Bharat Parenterals Ltd
Score 68/100• Decent
Bharat Parenterals Ltd shows potential for growth, but faces challenges in profitability and market competition.
Company’s Health64/100
Valuation 60/100 · PB 2.4589
Technical Avoid
1M -1.339% 6M 22.431% 1Y -17.682%
Confidence100%
No promoter pledgeDecent revenue growth
Weak ROEThin margins
#102
View details ➜
A
Asarfi Hospital Ltd
Score 68/100• Decent
Asarfi Hospital Ltd shows potential in a growing sector but faces challenges in profitability and valuation. Caution is advised.
Company’s Health89/100
Valuation 40/100 · PB 3.6711
Technical Momentum
1M 20.93% 6M 66.906% 1Y 89.301%
Confidence100%
No promoter pledgeDecent revenue growth
#103
View details ➜
A
Aspira Pathlab & Diagnostics Ltd
Score 68/100• Decent
Aspira Pathlab & Diagnostics Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised.
Company’s Health77/100
Valuation 40/100 · PB 4.6746
Technical Avoid
1M -7.719% 6M -5.538% 1Y 14.566%
Confidence100%
Low leverage (D/E)No promoter pledge
#104
View details ➜
A
Aristo Bio-Tech and Lifescience Ltd
Score 68/100• Decent
The company operates in a promising sector but faces challenges in growth consistency and profitability metrics.
Company’s Health72/100
Valuation 60/100 · PB 2.4073
Technical Avoid
1M 6.173% 6M -0.789% 1Y -8.301%
Confidence100%
No promoter pledgeDecent revenue growth
Weak ROEThin margins
#105
View details ➜
Showing 91 to 105 of 301 (21 Pages)